Science of HEATT®

Inspired by previous whole-body hyperthermia studies, Verthermia has conducted research on how this new treatment works on a cellular level.


History Behind HEATT®

Since the 1980s, Verthermia® has studied and refined HEATT®. Blood flows into our circuit, gently heats, then returns to the body as we raise the patient's whole-body temperature to 42° Celsius (107.6°F) to destroy, damage, or slow the growth of cancer cells. During HEATT®, the patient is closely monitored to ensure safety throughout the procedure.


Non-Invasive Mechanics

HEATT® provides whole-body hyperthermia cancer treatment through a perfusion based procedure that does not involve surgical resection of tumors or radiation.

Science of HEATT graphics


Why 42° Celsius?
42° Celsius (107.6°F) is the temperature at which whole-body hyperthermia is used to treat cancer. This heated environment creates an inhospitable environment for many types of cancer cells, killing, damaging or slowing their growth. This temperature can be accurately maintained within the patient's body and is specifically chosen as it has been shown to achieve the best results for cancer treatment. At this temperature, some cancer cells become more sensitive to other treatments like chemotherapy, immunotherapy, or radiation; potentially making HEATT® a treatment option for those who have already tried conventional therapies without success.


Clinical Trial Results

At Verthermia®, we believe that everyone should have access to effective cancer treatments and strive to provide our clients with the best care possible. We are committed to continuing research on whole-body hyperthermia so that we can provide the latest information on its efficacy in treating cancer. Our team has conducted clinical trials, which to date have shown positive patient outcomes with whole-body hyperthermia treatment.

Ovarian cancer trials icon

Ovarian Cancer Trial

Our ovarian cancer trial resulted in significant findings on the positive impacts of HEATT®. Patients overall experienced improved survival rates and daily living satisfaction.

Lung cancer trials icons

Lung Cancer Trial

Verthermia® trial patients with unresponsive lung cancer exceeded average life expectancy after receiving HEATT®.


Verthermia® Webinars

Our mission is to support our patients on their journey toward improved health and well-being. To this end, we provide a wealth of educational webinars, online resources, and panel discussions led by experts in hyperthermia therapy. In these sessions, you can learn more about the whole-body hyperthermia process including trial results, patient success stories, and more. We also provide our patients with in-depth information about the science and technology behind HEATT®.


Initial Treatment Qualifications

At Verthermia®, we prioritize the safety and well-being of our patients above all else. We uphold stringent standards to ensure that every patient undergoing whole-body hyperthermia cancer treatment will do so in a manner that guarantees their safety and minimizes potential complications. To be eligible for HEATT®, a patient must meet certain requirements. Contact us today if you would like more information about your candidacy.

  • The patient must be over 18 years of age to obtain treatment.
  • checkmark1
  • The patient must have an advanced cancer diagnosis.
  • checkmark1
  • The patient must be unresponsive to conventional treatments.
Science of HEATT graphic


How Does HEATT® Impact Treatment?
Hyperthermia works by increasing the temperature of the cancer cells, accomplishing direct cell death, cell damage, or slowing the cancer cell growth of susceptible cells.


Why Choose HEATT®?
HEATT® stands out from other hyperthermia treatments due to its unique approach of heating the blood directly, closely controlling body temperature while restoring electrolyte balance and fluid levels. Instead of conduction or convection (external) heating methods, HEATT® employs a patient's own blood to distribute heat for whole-body hyperthermia - a process that is non-invasive and completely free from any chemicals.


Frequently Asked Questions

We understand that learning about the science of whole-body hyperthermia cancer treatment is important for cancer patients and their families. Here are some frequently asked questions that can help you make an informed and confident decision about HEATT®.

What types of cancers does whole-body hyperthermia treat?

Whole-body hyperthermia has been used to treat a variety of solid cancers. Our largest experience to date is with ovarian and lung cancer but also breast, colorectal, pancreatic and sarcoma.

How long has whole-body hyperthermia been studied?

Whole-body hyperthermia has been studied as a possible cancer treatment since the early 1900s. In recent years, modern technology has enabled more accurate temperature control and monitoring of patients during whole-body hyperthermia treatments, which has opened up new possibilities. Our HEATT® process is a unique method of whole body hyperthermia treatment.

How does hyperthermia treatment extend potential life expectancy?

By utilizing our safe and precise application of heat to cancerous cells in order to achieve tumor destruction. Likewise, we may see a beneficial response from the body’s own defense mechanisms or increased sensitivity to other therapies.

Is hyperthermia cancer treatment safe?

HEATT® utilizes the patient's own blood to deliver a precise heating process. Our team of specialists is trained and experienced in managing this procedure safely, yet as with all treatments there may be some risks involved - which will be discussed thoroughly prior to treatment.

What should I expect after the treatment?

Once the treatment is complete, you will rest for several hours afterward in a recovery setting. Listen to your body and give it time to recover. Some patients may experience fatigue or other side effects up to a few days after the treatment. You will stay in close contact with your care provider throughout the recovery process.

How have our clinical trials helped develop HEATT®?

Our clinical trials have helped to refine the effectiveness of HEATT®. Through additional research and testing, we’ve been able to ensure that this innovative cancer treatment is as safe and effective as possible before offering it to our patients.

Who conducts the whole-body hyperthermia treatment process?

Hyperthermia treatments are conducted by a multidisciplinary team of medical professionals, including specialists in medicine, surgery, interventional radiology radiation and anesthesiology. This team works together to ensure that the patient is closely monitored throughout the entire treatment process.